VECURONIUM Drug Patent Profile
✉ Email this page to a colleague
When do Vecuronium patents expire, and what generic alternatives are available?
Vecuronium is a drug marketed by Eugia Pharma, Gland, Hikma, Hospira, Meitheal, Mylan Labs Ltd, Sagent Pharms Inc, Sun Pharm, and Watson Labs. and is included in twelve NDAs.
The generic ingredient in VECURONIUM is vecuronium bromide. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the vecuronium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vecuronium
A generic version of VECURONIUM was approved as vecuronium bromide by MEITHEAL on August 25th, 1999.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VECURONIUM?
- What are the global sales for VECURONIUM?
- What is Average Wholesale Price for VECURONIUM?
Summary for VECURONIUM
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 12 |
| DailyMed Link: | VECURONIUM at DailyMed |
US Patents and Regulatory Information for VECURONIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 206670-001 | Dec 20, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sagent Pharms Inc | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 078274-001 | Dec 29, 2008 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 203725-001 | Jul 30, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Gland | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 205390-002 | May 26, 2016 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
